Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder-Reference-Cited by-同舟云学术

Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder

Published:2018-09-28 Issue:76 Volume:9 Page:34357-34378
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Walliser Claudia¹,Wist Martin¹,Hermkes Elisabeth¹,Zhou Yuan¹,Schade Anja¹,Haas Jennifer¹,Deinzer Julia¹,Désiré Laurent²,Li Shawn S.C.³,Stilgenbauer Stephan⁴,Milner Joshua D.⁵,Gierschik Peter¹

Affiliation:

1. Institute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm 89070, Germany

2. Diaxonhit, Paris 75013, France

3. Department of Biochemistry and The Siebens-Drake Medical Research Institute, Schulich School of Medicine, University of Western Ontario, London, Ontario N6A 5C1, Canada

4. Department of Internal Medicine III, Ulm University Medical Center, Ulm 89070, Germany

5. Laboratory of Allergic Diseases, NIAID, NIH, Bethesda, MD 20892, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function – Insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

2. The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function – insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation;2023-11-02

3. Phospholipases in human cancers: A new therapeutic target;Phospholipases in Physiology and Pathology;2023

4. The Conformational State of the BTK Substrate PLCγ Contributes to Ibrutinib Resistance;Journal of Molecular Biology;2022-03

5. A novel likely pathogenic PLCG2 variant in a patient with a recurrent skin blistering disease and B-cell lymphopenia;European Journal of Medical Genetics;2022-01